Status:
COMPLETED
Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
AstraZeneca
Conditions:
Moderate to Severe COPD
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to study efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Inclusion
- FEV1 between 30 and 80% of predicted normal value post-bronchodilator (GOLD stages 2 and 3)
- Clinical diagnosis of COPD
Exclusion
- Other clinically relevant disease or disorders
- Exacerbation of COPD within 30 days
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT00690482
Start Date
May 1 2008
End Date
December 1 2008
Last Update
January 15 2014
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Pleven, Bulgaria
2
Research Site
Rousse, Bulgaria
3
Research Site
Sofia, Bulgaria
4
Research Site
Varna, Bulgaria